nalmefene and Acute Disease

nalmefene has been researched along with Acute Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Henderson, CA; Reynolds, JE	1
Clark, WM; Kelly, RE; Raps, EC; Tong, DC	1
Sareen, D	1

Reviews

1 review(s) available for nalmefene and Acute Disease

Article	Year
Neuroprotective agents in acute ischemic stroke. The Journal of the Association of Physicians of India, 2002, Volume: 50 Topics: Acute Disease; Adult; Aged; Animals; Antioxidants; Calcium Channel Blockers; Chlormethiazole; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Forecasting; GABA Modulators; Guanidines; Humans; Imidazoles; Middle Aged; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Pipecolic Acids; Piperidines; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Stroke; Thiazoles	2002

Article

Year

Neuroprotective agents in acute ischemic stroke.

The Journal of the Association of Physicians of India, 2002, Volume: 50

Topics: Acute Disease; Adult; Aged; Animals; Antioxidants; Calcium Channel Blockers; Chlormethiazole; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Forecasting; GABA Modulators; Guanidines; Humans; Imidazoles; Middle Aged; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Pipecolic Acids; Piperidines; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Stroke; Thiazoles

2002

Trials

1 trial(s) available for nalmefene and Acute Disease

Article	Year
Cervene (Nalmefene) in acute ischemic stroke : final results of a phase III efficacy study. The Cervene Stroke Study Investigators. Stroke, 2000, Volume: 31, Issue:6 Topics: Acute Disease; Aged; Aged, 80 and over; Brain Ischemia; Dose-Response Relationship, Drug; Double-Blind Method; Dynorphins; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Neuroprotective Agents; Receptors, Opioid, kappa; Risk Factors; Survival Analysis; Treatment Failure	2000

Article

Year

Cervene (Nalmefene) in acute ischemic stroke : final results of a phase III efficacy study. The Cervene Stroke Study Investigators.

Stroke, 2000, Volume: 31, Issue:6

Topics: Acute Disease; Aged; Aged, 80 and over; Brain Ischemia; Dose-Response Relationship, Drug; Double-Blind Method; Dynorphins; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Neuroprotective Agents; Receptors, Opioid, kappa; Risk Factors; Survival Analysis; Treatment Failure

2000

Other Studies

1 other study(ies) available for nalmefene and Acute Disease

Article	Year
Acute pulmonary edema in a young male after intravenous nalmefene. Anesthesia and analgesia, 1997, Volume: 84, Issue:1 Topics: Acute Disease; Adult; Analgesics, Opioid; Anesthesia; Humans; Infusions, Intravenous; Male; Morphine; Naltrexone; Narcotic Antagonists; Pulmonary Edema	1997